Medical researchers have discovered a way to stimulate the brain's natural defense mechanisms in people with Alzheimer's disease.
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
Your new post is loading...
Your new post is loading...
|
A team of researchers from Université Laval, CHU de Québec, and pharmaceutical firm GlaxoSmithKline (GSK) has discovered a way to stimulate the brain's natural defense mechanisms in people with Alzheimer's disease. This major breakthrough, details of which are presented January 15 in an early online edition of the Proceedings of the National Academy of Sciences (PNAS), opens the door to the development of a treatment for Alzheimer's disease and a vaccine to prevent the illness.
DIRECT LINK TO THE PNAS PAPER:
http://www.pnas.org/content/early/2013/01/15/1215165110.abstract?sid=77e73b2c-8672-4359-897b-20c360c991b7
Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer’s disease-related pathologyJean-Philippe Michauda,Maxime Halléb,Antoine Lamprona,Peter Thériaulta,Paul Préfontainea,Mohammed Filalia,Pascale Tribout-Joverb,Anne-Marie Lanteigneb,Rachel Jodoinb,Christopher Cluffc,Vincent Brichardd,Rémi Palmantierd,Anthony Pilorgetb,Daniel Larocqueb,1, andSerge Rivesta,1